Welcome to our dedicated page for Church & Dwight news (Ticker: CHD), a resource for investors and traders seeking the latest updates and insights on Church & Dwight stock.
Church & Dwight Co., Inc. reports developments for a consumer products manufacturer built around sodium bicarbonate, household care, personal care and specialty products. Its updates commonly cover sales trends across Consumer Domestic, International and Specialty Products, brand performance for ARM & HAMMER, OXICLEAN, THERABREATH, HERO, WATERPIK, BATISTE and TOUCHLAND, and launches in cat litter, oral care and other household or personal care categories.
Company news also includes dividend declarations, earnings webcasts, analyst presentations, acquisition and portfolio actions, productivity and margin commentary, and cash-flow uses tied to brand investment and acquisitions.
Church & Dwight Co. (NYSE:CHD) has declared a quarterly dividend of $0.2625 per share. This dividend will be paid on June 1, 2022 to shareholders on record as of May 16, 2022. This marks the company's 485th consecutive quarterly dividend, demonstrating its commitment to returning value to shareholders. Church & Dwight is known for its diverse range of personal care, household, and specialty products, particularly under the Arm & Hammer brand.
Church & Dwight Co. (NYSE:CHD) will conduct a conference call on April 28, 2022, at 10:00 a.m. Eastern time to discuss its first quarter 2022 earnings. Participants can join by dialing 877-322-9846 (U.S./Canada) or 631-291-4539 (international) with access code 7619748. A replay will be available two hours after the call. Church & Dwight, founded in 1846, is a leading U.S. producer of sodium bicarbonate and markets various products under well-known brands, contributing to approximately 80% of its sales.
Church & Dwight Co. (NYSE: CHD) will present at the 2022 Consumer Analyst Group of New York (CAGNY) Virtual Conference on February 23, 2022, at 12:40 p.m. ET. The event will be broadcast online, accessible through their investor relations page. Founded in 1846, Church & Dwight is the leading U.S. producer of sodium bicarbonate and offers a diverse assortment of personal care and household products under renowned brands such as ARM & HAMMER and TROJAN. These brands make up approximately 85% of the company's product sales.
Church & Dwight Co. reported a 6% increase in net sales for 2021, totaling $5,190.1 million, driven by strong consumer demand. Q4 net sales reached $1,368.7 million, exceeding expectations with 5.7% growth. Adjusted EPS for 2021 rose 6.7% to $3.02, with Q4 EPS at $0.64, an 8.5% increase year-over-year. The company plans significant investments in 2022 to expand capacity amid ongoing supply chain challenges. A 4% dividend increase was announced, marking 26 consecutive years of growth.
Church & Dwight Co., Inc. (NYSE:CHD) has finalized the acquisition of TheraBreath®, the second-largest brand in the alcohol-free mouthwash category in the U.S. The $580 million cash transaction was initially announced on November 29, 2021. CEO Matthew T. Farrell emphasized the strategic importance of oral care, noting TheraBreath® will enhance the company's portfolio, which already includes well-known brands like ARM & HAMMER® and ORAJEL®. The acquisition positions CHD strongly within a growing market segment.
Church & Dwight Co. (NYSE: CHD) will host a live webcast on January 28, 2022, at 10:00 a.m. (ET), to discuss its fourth quarter and year-end 2021 results. Investors can access the presentation online at this link. For those preferring to listen only, call 877-322-9846 in the U.S. or 631-291-4539 internationally with access code 6747988. Founded in 1846, Church & Dwight is a leading producer of sodium bicarbonate and markets numerous well-known brands, including ARM & HAMMER and TROJAN.
Church & Dwight Co. (NYSE:CHD) has agreed to acquire the TheraBreath brand for $580 million in cash, pending regulatory approval.
TheraBreath has a trailing twelve months net sales of approximately $86 million and EBITDA of $27 million with a 31% margin. The acquisition is expected to yield $6 million in operating synergies by 2023 and bolster Church & Dwight's oral care portfolio.
Projected 2022 sales for TheraBreath are $100 million, with adjusted EBITDA of $36 million, but the deal may dilute 2021 EPS by $0.03.
Church & Dwight Co. (NYSE: CHD) reported a 5.7% increase in net sales for Q3 2021, totaling $1,311.4 million. Organic sales rose 3.7%, beating the forecast of 1.5%. EPS increased 8.2% to $0.92, while adjusted EPS grew 14.3% to $0.80. The company faces challenges from supply chain disruptions due to Hurricane Ida, impacting gross margins, which fell 130 basis points to 44.2%. Despite inflation pressures, CHD raised its full-year net sales guidance to 5.5% and organic sales to 4%.
Church & Dwight Co. declared a regular quarterly dividend of $0.2525 per share, marking its 483rd consecutive quarterly dividend. This dividend will be payable on December 1, 2021, to stockholders of record as of November 15, 2021. The company, known for its Arm & Hammer brand, focuses on manufacturing a diverse range of personal care and household products.
Church & Dwight Co. will host a conference call on October 29, 2021, at 10:00 a.m. Eastern time to discuss its third quarter 2021 earnings results. Participants can join by calling 877-322-9846 in the U.S. or Canada, and 631-291-4539 internationally, using access code 22670478. A replay will be available two hours after the call. The company is well-known for brands such as ARM & HAMMER, TROJAN, and OXICLEAN, and is a leading producer of sodium bicarbonate, founded in 1846.